SUMMARY
We recently published genetic lineage-tracing experiments using the Fezf2 and Cux2 loci. These experiments demonstrated that at both the clonal and population levels Fezf2 + RGCs are multipotent and that at the population level Cux2 + RGCs are multipotent. Here, we extend our work on the lineages of Fezf2 + and Cux2 + RGCs. Clonal analysis of E10.5 neocortical progenitors suggests that most, if not all, Cux2
+ and Fezf2 + RGCs generate diverse projection neuron subtypes located throughout layers 2-6. These results support our previous conclusion that both Fezf2 + and Cux2 + RGCs are multipotent neocortical progenitors. This Matters Arising Response paper addresses the Gil-Sanz et al. (2015) Matters Arising paper, published concurrently in Neuron.
INTRODUCTION
Recent work proposes that the neocortex contains distinct classes of radial glial cells (RGCs), which are intrinsically predisposed to generate either deep or upper layer projection neurons. This model is based upon genetic lineage-tracing experiments, which concluded that early (embryonic day 10.5 [E10.5]) RGCs labeled by Cux2-Cre or Cux2-CreER T2 -mediated recombination (Cux2 + ) are fated to generate corticocortical projection neurons that reside primarily within upper layers (Franco et al., 2012) .
We recently published a study in which we tested this model using genetic lineage tracing with the Fezf2 and Cux2 loci. This work demonstrated that: (1) Fezf2-expressing (Fezf2 + ) RGCs are multipotent and sequentially generate deep and upper layer cortical projection neurons followed by macroglia and (2) mice indicates that most, if not all, early RGCs labeled by these alleles generate multiple subtypes of cortical projection neurons located in layers 2-6. These results reinforce our previous conclusion that both Fezf2 + and Cux2 + RGCs are multipotent neocortical progenitors (Guo et al., 2013) .
RESULTS
The Cux2-Cre Allele Is Not Suitable for Lineage Tracing of Neocortical RGCs A significant difference between our previous study (Guo et al., 2013) and the work of Franco et al. (2012) and Gil-Sanz et al. (2015) is that the latter two studies relied extensively on the Cux2-Cre allele to analyze the lineages of RGCs. This allele expresses a constitutively active form of Cre that, when utilized in combination with Cre-dependent reporters, permanently labels any cell in which the Cux2 locus has been, or is currently, active. In addition, any cell derived from a Cux2 + progenitor will be permanently labeled.
We reported that at E15.5, Cux2-Cre labeled RGCs, basal progenitors, and postmitotic neurons, thus masking the true lineage of Cux2 + RGCs (Guo et al., 2013) . To demonstrate this further, we bred heterozygous Cux2-Cre mice to homozygous RCE-GFP and Ai9 reporter mice and examined the brains of double heterozygous mice at postnatal day 28 (P28) (Figures S1A and S1B and data not shown). We observed strong fluorescence throughout all cortical layers. Although in some cases labeling of cell bodies was evident ( Figure S1B ), high levels of reporter expression in neurites complicated the analysis of labeled cell bodies.
To circumvent this, we examined publicly available data from the Allen Brain Atlas (ABA), which includes extensive analysis of the same Cux2-Cre and Cux2-CreER T2 alleles that were used in previous lineage studies (Franco et al., 2012; Guo et al., 2013) . The ABA datasets include in situ hybridization (ISH) experiments for Cre, Cux2, and tdTomato, which facilitate high-resolution analysis of cell bodies labeled by the Cre-dependent tdTomato reporter Ai14 (Madisen et al., 2010) . Analysis of P58 Cux2-Cre; Ai14 mice indicated that Cre expression closely mimicked Cux2 expression (Figures S1C-S1F ). Both Cux2 and Cre transcripts were highly enriched within upper cortical layers (L2-L4) with sparse expression in deep layers (L5 and L6 Figures S2D2 and S2H2 with S2B-S2D1 and S2F-S2H1). This indicates that a thorough examination of reporter expression across multiple cortical areas is required to fully understand the extent of cell labeling by the Cux2-Cre allele, as it has a complex temporal and spatial expression pattern ( Figure 1A) .
The preceding analysis demonstrates that, in the adult brain, the Cux2-Cre allele labels cells that are present in both deep and upper cortical layers, including cells that no longer express Cux2 at adult stages. Importantly, the recombinase activity of Cux2-Cre in both progenitor cells and postmitotic neurons makes it unsuitable for lineage analysis of neocortical RGCs, because the possibility cannot be excluded that Cux2-Cremediated recombination was initiated in postmitotic neurons ( Figure 1A (Chen et al., 2008; Miyoshi and Fishell, 2012 ) ( Figure 1B ). We injected tamoxifen at 100 mg per kg of body weight, a concentration that reliably generated sparse labeling in the cortices of these mice. Whole-mount examination of the brains revealed sparse columns of reporter + cells (Figure S3A) , suggesting that these cells may be clonally related.
Although we refer to the spatially isolated columns of labeled cells as clones, we cannot exclude the possibility that some of the clones may consist of progeny from more than one RGC. This caveat, however, does not change the interpretation of our analysis with regard to the lack of lineage restriction within the Cux2 + RGC lineage.
To examine the progeny of early Cux2 + RGCs, we analyzed serial brain sections and reconstructed 43 clones from 6 mice (Figures 1C-1D and S3C and Table S1 ). We focused our analysis on spatially isolated columns of cells that predominantly consisted of projection neurons and macroglia. We excluded individual cells that were sparsely distributed throughout the cortex, as they were likely labeled interneurons. The number of cells in each clone varied from 13 to 227 with an average of 83 cells per clone ( Figure 1E and Table S1 ). Cells in the clones spanned an average of 350 mm along the rostral-caudal axis (Table S1 ). The number of cells per clone and physical dispersion of the cells in the clones is similar to that reported for E10.5 RGC clones in a recent study that utilized Mosaic Analysis with Double Markers (MADM) to label RGC progeny at clonal density (Gao et al., 2014) . Of the 43 reconstructed clones, 30 (70%) contained both neurons and glia, while 13 (30%) consisted of only neurons (Table S1 ). Strikingly, 100% of the E10.5 Cux2-CreER T2 -labeled clones that we examined contained projection neurons located in cortical layers 2-6 ( Figures 1C-1D and S3C ). The 43 reconstituted clones contained a total of 3,562 lineage-traced cells of which 90% exhibited a characteristic neuronal morphology while 10% exhibited glial morphologies ( Figure 1F and Table S1 ). Analysis of the 3,188 lineage-traced neurons demonstrated that their distribution in deep and upper layers was roughly equivalent (legend continued on next page) (55% upper layer neurons versus 45% deep layer neurons) ( Figure 1G and Table S1 ). This distribution of lineage-traced neurons is similar to that observed in lineage-tracing experiments of E10.5 RGCs using the Nestin-CreER T2 (Franco et al., 2012) , Emx1-CreER T2 (Gao et. al. 2014), and Fezf2-CreER T2 alleles ( Figure 3 and Table S1 ). These results provide strong evidence that most, if not all, individual Cux2 + RGCs are multipotent and generate projection neurons in cortical layers 2-6 and macroglia. Figures   2F-2J ). We also investigated molecular expression profiles using a combination of antibodies against CTIP2 and SATB2, another projection neuron marker (Alcamo et al., 2008; Britanova et al., 2008) . Within L5 and L6, 35.8% ± 5.7% of lineage-traced neurons expressed SATB2 and 13.2% ± 2.5% expressed both SATB2 and CTIP2 ( Figures 2K-2O and 2AA ). Thus, within deep cortical layers, projection neurons generated from E10. (Guo et al., 2013) . To extend our clonal analysis of Fezf2 + RGCs, we bred Fezf2-CreER T2 animals to RCE-GFP or Ai9 reporter mice, administered a single low dose of tamoxifen at E10.5, and analyzed brains at P10 ( Figure 3A) . We reconstituted 46 clones from 3 animals ( Figures 3B-3C and S3D and Table S1 ). The number of cells in each clone varied from 13 to 242 with an average of 67 cells per clone, and the clones spanned an average of 300 mm along the rostral-caudal axis ( Figure 3D and Table S1 ). Twenty-eight percent of the clones contained only neurons, and 72% contained both neurons and glia. Similar to E10.5 Cux2 + RGCs, 100% of Fezf2 + RGC clones contained neurons located throughout cortical layers 2-6 ( Figures 3B-3C and S3D). We quantified the distribution of the 3,100 lineage-traced cells in the 46 E10.5 Fezf2 clones and found that, comparable to results from clonal analysis using the Cux2-CreER T2 allele, Fezf2 + RGCs generated projection neurons (88%) and glia (12%) ( Figure 3E and Table S1 ). Lineage-traced neurons were located in both deep (44%) and upper (56%) layers (Figures  3B-3C and 3F and Table S1 ). We examined 2,328 deep layer lineage-traced neurons from 3 brains that consisted of both fully and partially reconstructed clones and found that 26.8% ± 5.0% of these neurons expressed CTIP2 ( Figure 3G ). When lineage-traced neurons were analyzed using antibodies for CTIP2 and TBR1, 23.5% ± 3.0% of deep layer neurons expressed TBR1 alone, and 8.8% ± 2.9% expressed both CTIP2 and TBR1 ( Figure 3G ). We also analyzed reporter + neurons in L5 and L6 using a combination of CTIP2
and SATB2 antibodies and found that 30.8% ± 1.4% expressed SATB2 alone, and 7.6% ± 3.3% expressed both SATB2 and CTIP2 ( Figure 3G ). Within upper cortical layers, lineage-traced neurons expressed CUX1 (47.1% ± 5.9%) or SATB2 (59.7% ± 4.7%) ( Figure 3G) . Notably, the percentage of lineage-traced neurons that expressed each of these markers is similar to that observed with TM at E10.5; P10 Cux2-CreER T2 mice ( Figures  2AA, 3G, and 3H) . Collectively, our clonal and molecular analyses suggest that both Fezf2 + RGCs and Cux2 + RGCs are multipotent and generate multiple subtypes of projection neurons and macroglia.
Retrograde Tracing Confirms that Cux2 + RGCs Generate Subcerebral Projection Neurons Thus far, we have provided evidence that Cux2 + RGCs generate neurons located in deep cortical layers that also express molecular markers for subcerebral projection neurons. To confirm that these neurons extend axons to subcerebral targets, we combined Cre-dependent lineage analysis with retrograde tracing ( Figure 4A ). We bred heterozygous Cux2-CreER T2 mice to 
P10). Lineage-traced neurons expressed TBR1 (A-E), DARPP32 (F-J), SATB2 (K-O), CUX1 (P-T), or CTIP2 (A-T). (B)-(E), (G)-(J), (L)-(O), and (Q)-(T) show the higher-magnification images of the boxed areas in (A), (F), (K), and (P), respectively. The arrowheads in (B)-(E), (G)-(J), (L)-(O), and (Q)-(T) point to cells (legend continued on next page)
homozygous RCE-GFP reporter mice, and administered a single dose of tamoxifen at E10.5 (100 mg/kg), to mark the progeny of Cux2 + RGCs. We then injected cholera toxin beta (Ctß) into the pyramidal tract at P8 (Figures 4A and S3B) . Ctß injection into the pyramidal tract labeled a subset of subcerebral projection neurons located in layer 5 ( Figure 4C) . Notably, we observed GFP; Ctß double-positive cells in Cux2-CreER T2 ; RCE-GFP mice, indicating that these subcerebral neurons were generated from Cux2 + RGCs (Figures 4D-4F) .
We quantified the percentage of GFP + cells derived from Cux2 + RGCs that projected subcerebral axons in Cux2-CreER T2 ; RCE-GFP brains. We found that 11.5% ± 1.1% of GFP + cells in layer 5 and 4.4% ± 0.4% of GFP + cells in layers 5 and 6 were retrogradely traced ( Figure 4B ). We performed a similar analysis using the Fezf2-CreER T2 allele , which was previously shown to label RGCs that generate neurons that project axons to the corpus callosum, thalamus, and spinal cord (Guo et al., 2013 
DISCUSSION
Our previous study demonstrated that at both the clonal and population levels Fezf2 + RGCs are multipotent and that at the population level Cux2 + RGCs are multipotent (Guo et al., 2013) . This result suggested that either all Cux2 + RGCs are multipotent or, alternatively, Cux2 + RGCs might represent a heterogeneous population with different lineage potentials. Herein, our lineage analysis of individual Cux2 + RGCs provides evidence that most, if not all, Cux2 + RGCs are multipotent and generate diverse projection neuron subtypes located in cortical layers 2-6. Further, we found that the laminar distribution and molecular expression profile of neurons generated from early Cux2 + RGCs was similar to that of neurons generated from early Fezf2 + RGCs (Figure 3 ), Nestin-CreER T2+ RGCs (Franco et al., 2012) , and Emx1-CreER T2+ RGCs (Gao et al., 2014) .
Using the Cux2-Cre and Cux2-CreER T2 alleles, Franco et al. (2012) reported that Cux2 + RGCs generated only neurons and not glia. They also reported that among the progeny generated by E10.5 Cux2-CreER T2 -labeled RGCs, 90% of labeled cells were located in upper cortical layers while 10% were in deep layers. These data are significantly different from our previous and current results. By using two Cre reporter lines, RCE-GFP and Ai9, analyzing 6,258 lineage-traced cells, and reconstructing 43 RGC clones, we observed that at P10 roughly 10% of cells generated from E10.5 Cux2 + RGCs were astrocytes or oligodendrocytes. Moreover, we found that every E10.5 RGC clone we examined contained neurons located in both deep and upper cortical layers and that there was not a strong bias of the labeled cells to occupy upper cortical layers. Both the current study and Gil-Sanz et al. (2015) Figure S4 ; see also Figure 3E of Gil-Sanz et al. [2015] ). Thus, it is not surprising that a multipotent RGC, which generates diverse subtypes of projection neurons, can produce a higher percentage of SATB2 + than CTIP2 + progeny. This highlights the need to define projection neuron subtype identity using multiple parameters, including additional molecular markers and axonal projections. Toward this, we found that a similar percentage of neurons with subcerebral projections were born from Cux2 + RGCs and Fezf2 + RGCs labeled at E10.5 (Figure 4) . Gil-Sanz et al. (2015) attribute the difference in results between experiments performed in the Mü ller laboratory (Franco et al., 2012; Gil-Sanz et al., 2015) and our work (Guo et al., 2013 and current study) to breeding strategy and genetic background. The authors propose that the low recombination efficiency we observe in Cux2-CreER T2 mice at E10.5, using a TM dosage of 100 mg/kg of body weight, is an artifact of genetic background. Furthermore, they suggest that our lineage analysis results with the Cux2-CreER T2 allele are highly influenced by genetic background. GilSanz et al. (2015) report that the Cux2-CreER T2 allele previously induced more widespread recombination at a TM dosage of 50 mg/kg when compared to the current study. We disagree; our interpretation of Figure S2 from Franco et al. (2012) is that sparse recombination was prevalent at this dosage, similar to results from our laboratory. Moreover, in Gil-Sanz et al. (2015) , the authors injected 4-hydroxytamoxifen (4-OHT) at a dosage of 50 mg/kg of body weight (or 1 mg/20 g) to achieve sparse labeling of E10.5 Cux2 + RGCs. However, 4-OHT has a much greater affinity (503-1003) than TM for binding estrogen receptors (Malet et al., 1988) and is significantly more potent at inducing recombination (Hans et al., 2009 ). Thus, the recombination efficiency of the Cux2-CreER T2 allele in studies from the Mü ller laboratory does not appear to be significantly higher than that observed in our laboratory (compare Figures 1 and 2 in the current study with Figures 3 and S3D -S3I of Gil-Sanz et al. [2015] ).
One explanation for the divergent conclusions reached by our work and that of Franco et al. (2012) and Gil-Sanz et al. (2015) is that the latter two studies relied heavily on Cux2-Cre mice, which are not suitable for lineage analysis of neocortical RGCs. Here we present evidence that explains why the lineage analysis of neocortical RGCs is confounded by the complex temporal and spatial expression pattern of the Cux2-Cre allele. The recombinase activity of Cre driven from the Cux2 locus is constitutively active and thus recombination can occur in RGCs, basal reported that 100% of clones generated from RGCs labeled at E10.5 contained neurons that occupied cortical layers 2-6. Notably, despite the differences in recombination efficiency between the MADM strategy and our current study, the average numbers of cells per clone and rostral-caudal dispersion of cells in the clones are similar between the two studies. Moreover, by analyzing subtype-specific markers, Gao et al. (2014) found that individual clones contained cells expressing markers for multiple subclasses of neocortical projection neurons. Combined with the current study, this work provides important evidence for the prevalence of multipotent RGCs within the early neocortical progenitor pool.
Collectively, our results demonstrate that early Cux2 + and these findings do not exclude the existence of fate-restricted RGCs during early cortical development. Rather, they indicate that neither Fezf2 nor Cux2 expression alone is sufficient to identify these cells and that appropriate molecular or genetic markers await future investigation.
EXPERIMENTAL PROCEDURES
All experiments were carried out in accordance with the protocols approved by the IACUC at University of California at Santa Cruz and institutional and federal guidelines. The day of vaginal plug detection was designated as E0.5. The day of birth was designated as P0. Immunohistochemistry was performed as previously described (Eckler et al., 2011) . Extended experimental details are included in Supplemental Experimental Procedures.
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